The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Total Artificial Heart Market Research Report 2024
Synopsis
Total Artificial Heart (TAH) is a prosthetic device that is implanted into the body to replace the biological heart. A few proprietary artificial heart devices have been developed including the Syncardia TAH, AbioCor (Abiomed, Danvers, Massachusetts, USA), and CARMAT (Carmat, Velizy, France). The history of these devices and their clinical use has recently been reviewed. Among the devices listed, the Syncardia (TAH) is the only device currently in use. The CARMAT is currently undergoing feasibility studies, however, data has been limited to a handful of patients thus far. There is also no data on the use of the AbioCor or CARMAT in patients with CHD.
The global Total Artificial Heart market was valued at US$ 39 million in 2023 and is anticipated to reach US$ 156.5 million by 2030, witnessing a CAGR of 21.7% during the forecast period 2024-2030.
Global Total Artificial Heart key players include only SynCardia, with a share about 100%. North America is the largest market, with a share about 60%, followed by Europe, with a share about 40 percent. In terms of product, SynCardia is the largest segment, with a share about 100%. And in terms of application, the largest application is Ischemic Cardiomyopathy, followed by Dilated Cardiomyopathy, etc.
This report aims to provide a comprehensive presentation of the global market for Total Artificial Heart, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Total Artificial Heart.
Report Scope
The Total Artificial Heart market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Total Artificial Heart market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Total Artificial Heart manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BiVACOR
SynCardia
Jarvik Heart
CARMAT
AbioMed
Segment by Type
SynCardia
Others
Segment by Application
Dilated Cardiomyopathy
Ischemic Cardiomyopathy
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Total Artificial Heart manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Total Artificial Heart in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Total Artificial Heart (TAH) is a prosthetic device that is implanted into the body to replace the biological heart. A few proprietary artificial heart devices have been developed including the Syncardia TAH, AbioCor (Abiomed, Danvers, Massachusetts, USA), and CARMAT (Carmat, Velizy, France). The history of these devices and their clinical use has recently been reviewed. Among the devices listed, the Syncardia (TAH) is the only device currently in use. The CARMAT is currently undergoing feasibility studies, however, data has been limited to a handful of patients thus far. There is also no data on the use of the AbioCor or CARMAT in patients with CHD.
The global Total Artificial Heart market was valued at US$ 39 million in 2023 and is anticipated to reach US$ 156.5 million by 2030, witnessing a CAGR of 21.7% during the forecast period 2024-2030.
Global Total Artificial Heart key players include only SynCardia, with a share about 100%. North America is the largest market, with a share about 60%, followed by Europe, with a share about 40 percent. In terms of product, SynCardia is the largest segment, with a share about 100%. And in terms of application, the largest application is Ischemic Cardiomyopathy, followed by Dilated Cardiomyopathy, etc.
This report aims to provide a comprehensive presentation of the global market for Total Artificial Heart, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Total Artificial Heart.
Report Scope
The Total Artificial Heart market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Total Artificial Heart market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Total Artificial Heart manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BiVACOR
SynCardia
Jarvik Heart
CARMAT
AbioMed
Segment by Type
SynCardia
Others
Segment by Application
Dilated Cardiomyopathy
Ischemic Cardiomyopathy
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Total Artificial Heart manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Total Artificial Heart in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Total Artificial Heart Market Overview
1.1 Product Overview and Scope of Total Artificial Heart
1.2 Total Artificial Heart Segment by Type
1.2.1 Global Total Artificial Heart Market Value Comparison by Type (2024-2030)
1.2.2 SynCardia
1.2.3 Others
1.3 Total Artificial Heart Segment by Application
1.3.1 Global Total Artificial Heart Market Value by Application: (2024-2030)
1.3.2 Dilated Cardiomyopathy
1.3.3 Ischemic Cardiomyopathy
1.3.4 Others
1.4 Global Total Artificial Heart Market Size Estimates and Forecasts
1.4.1 Global Total Artificial Heart Revenue 2019-2030
1.4.2 Global Total Artificial Heart Sales 2019-2030
1.4.3 Global Total Artificial Heart Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Total Artificial Heart Market Competition by Manufacturers
2.1 Global Total Artificial Heart Sales Market Share by Manufacturers (2019-2024)
2.2 Global Total Artificial Heart Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Total Artificial Heart Average Price by Manufacturers (2019-2024)
2.4 Global Total Artificial Heart Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Total Artificial Heart, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Total Artificial Heart, Product Type & Application
2.7 Total Artificial Heart Market Competitive Situation and Trends
2.7.1 Total Artificial Heart Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Total Artificial Heart Players Market Share by Revenue
2.7.3 Global Total Artificial Heart Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Total Artificial Heart Retrospective Market Scenario by Region
3.1 Global Total Artificial Heart Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Total Artificial Heart Global Total Artificial Heart Sales by Region: 2019-2030
3.2.1 Global Total Artificial Heart Sales by Region: 2019-2024
3.2.2 Global Total Artificial Heart Sales by Region: 2025-2030
3.3 Global Total Artificial Heart Global Total Artificial Heart Revenue by Region: 2019-2030
3.3.1 Global Total Artificial Heart Revenue by Region: 2019-2024
3.3.2 Global Total Artificial Heart Revenue by Region: 2025-2030
3.4 North America Total Artificial Heart Market Facts & Figures by Country
3.4.1 North America Total Artificial Heart Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Total Artificial Heart Sales by Country (2019-2030)
3.4.3 North America Total Artificial Heart Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Total Artificial Heart Market Facts & Figures by Country
3.5.1 Europe Total Artificial Heart Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Total Artificial Heart Sales by Country (2019-2030)
3.5.3 Europe Total Artificial Heart Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Total Artificial Heart Market Facts & Figures by Country
3.6.1 Asia Pacific Total Artificial Heart Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Total Artificial Heart Sales by Country (2019-2030)
3.6.3 Asia Pacific Total Artificial Heart Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Total Artificial Heart Market Facts & Figures by Country
3.7.1 Latin America Total Artificial Heart Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Total Artificial Heart Sales by Country (2019-2030)
3.7.3 Latin America Total Artificial Heart Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Total Artificial Heart Market Facts & Figures by Country
3.8.1 Middle East and Africa Total Artificial Heart Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Total Artificial Heart Sales by Country (2019-2030)
3.8.3 Middle East and Africa Total Artificial Heart Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Total Artificial Heart Sales by Type (2019-2030)
4.1.1 Global Total Artificial Heart Sales by Type (2019-2024)
4.1.2 Global Total Artificial Heart Sales by Type (2025-2030)
4.1.3 Global Total Artificial Heart Sales Market Share by Type (2019-2030)
4.2 Global Total Artificial Heart Revenue by Type (2019-2030)
4.2.1 Global Total Artificial Heart Revenue by Type (2019-2024)
4.2.2 Global Total Artificial Heart Revenue by Type (2025-2030)
4.2.3 Global Total Artificial Heart Revenue Market Share by Type (2019-2030)
4.3 Global Total Artificial Heart Price by Type (2019-2030)
5 Segment by Application
5.1 Global Total Artificial Heart Sales by Application (2019-2030)
5.1.1 Global Total Artificial Heart Sales by Application (2019-2024)
5.1.2 Global Total Artificial Heart Sales by Application (2025-2030)
5.1.3 Global Total Artificial Heart Sales Market Share by Application (2019-2030)
5.2 Global Total Artificial Heart Revenue by Application (2019-2030)
5.2.1 Global Total Artificial Heart Revenue by Application (2019-2024)
5.2.2 Global Total Artificial Heart Revenue by Application (2025-2030)
5.2.3 Global Total Artificial Heart Revenue Market Share by Application (2019-2030)
5.3 Global Total Artificial Heart Price by Application (2019-2030)
6 Key Companies Profiled
6.1 BiVACOR
6.1.1 BiVACOR Corporation Information
6.1.2 BiVACOR Description and Business Overview
6.1.3 BiVACOR Total Artificial Heart Sales, Revenue and Gross Margin (2019-2024)
6.1.4 BiVACOR Total Artificial Heart Product Portfolio
6.1.5 BiVACOR Recent Developments/Updates
6.2 SynCardia
6.2.1 SynCardia Corporation Information
6.2.2 SynCardia Description and Business Overview
6.2.3 SynCardia Total Artificial Heart Sales, Revenue and Gross Margin (2019-2024)
6.2.4 SynCardia Total Artificial Heart Product Portfolio
6.2.5 SynCardia Recent Developments/Updates
6.3 Jarvik Heart
6.3.1 Jarvik Heart Corporation Information
6.3.2 Jarvik Heart Description and Business Overview
6.3.3 Jarvik Heart Total Artificial Heart Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Jarvik Heart Total Artificial Heart Product Portfolio
6.3.5 Jarvik Heart Recent Developments/Updates
6.4 CARMAT
6.4.1 CARMAT Corporation Information
6.4.2 CARMAT Description and Business Overview
6.4.3 CARMAT Total Artificial Heart Sales, Revenue and Gross Margin (2019-2024)
6.4.4 CARMAT Total Artificial Heart Product Portfolio
6.4.5 CARMAT Recent Developments/Updates
6.5 AbioMed
6.5.1 AbioMed Corporation Information
6.5.2 AbioMed Description and Business Overview
6.5.3 AbioMed Total Artificial Heart Sales, Revenue and Gross Margin (2019-2024)
6.5.4 AbioMed Total Artificial Heart Product Portfolio
6.5.5 AbioMed Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Total Artificial Heart Industry Chain Analysis
7.2 Total Artificial Heart Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Total Artificial Heart Production Mode & Process
7.4 Total Artificial Heart Sales and Marketing
7.4.1 Total Artificial Heart Sales Channels
7.4.2 Total Artificial Heart Distributors
7.5 Total Artificial Heart Customers
8 Total Artificial Heart Market Dynamics
8.1 Total Artificial Heart Industry Trends
8.2 Total Artificial Heart Market Drivers
8.3 Total Artificial Heart Market Challenges
8.4 Total Artificial Heart Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
